Essa Pharma Inc (ESSQF) 11.2221 $ESSQF ESSA Pharma Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Essa Pharma Inc (ESSQF) 11.2221 $ESSQF

ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market
PR Newswire - Thu Jul 02, 5:16PM CDT
ESSA Pharma Inc. ("ESSA" or the "Company" (TSX-V: EPI) announced today that its common shares have been approved for listing and trading on the NASDAQ Capital Market ("NASDAQ" under the symbol "EPIX".
EPI.VN: 10.910 (-0.590)

ESSA Pharma Inc. Announces Appointment of New Director
PR Newswire - Wed Jun 24, 3:20PM CDT
ESSA Pharma Inc. ("ESSA" or the "Company" (TSX-V: EPI) announced today that it has appointed Dr. David Parkinson to its board of directors. Dr. Parkinson's appointment as an independent director is effective immediately.
EPI.VN: 10.910 (-0.590)

Essa Pharma Inc. Reports Second Quarter 2015 Financial Results
CNW Group - Thu May 28, 5:19PM CDT
ESSA Pharma Inc. ("ESSA" or the "Company" (TSX-V: EPI) today reported financial results for the second quarter and three and six months ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with International Financial Reporting Standards ("IFRS".
EPI.VN: 10.910 (-0.590)

ESSA Pharma Inc. Receives FDA Response on IND Application
CNW Group - Mon May 04, 6:00AM CDT
ESSA Pharma Inc. ("ESSA" or the "Company" (TSX-V: EPI) announced today that it has received notification from the Food and Drug Administration ("FDA" or the "Agency" in the US that the Company's IND application, filed March 31, 2015, has been placed on clinical hold pending receipt by the FDA of additional chemistry and pharmaceutical data related to the stability of the drug substance and drug product and a Certificate of Analysis on drug product.
EPI.VN: 10.910 (-0.590)

ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506
CNW Group - Tue Mar 31, 2:01PM CDT
ESSA Pharma Inc. ("ESSA" or the "Company" (TSX-V: EPI) announced today that it has filed with the Food and Drug Administration ("FDA" in the US an Investigation New Drug ("IND" application related to the Company's proposed clinical trial of EPI-506 in prostate cancer patients. Approval of the IND application is required in order for ESSA to commence human testing of EPI-506 in the US.
EPI.VN: 10.910 (-0.590)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ingram Micro Joins S&P SmallCap 600 Amid M&A Moves

Updated Category News Views 65

Market Shufflin’ as Ingram Micro Steps In The constant ebb and flow of the stock market got right interesting with Ingram Micro Holding Corp. (NYSE: INGM) slated to crawl into the S&P SmallCap 600. This dance change-up is all thanks to Viatris Inc. (NASD: VTRS) looking to wrap up its acquisition of Pacira BioSciences (NASD: PCRX). With this deal sealing the fate of...

Continue Reading
Pearl Meyer Leaders Grab NACD's Coveted Governance Honor

Updated Category News Views 31

NACD Recognition for Governance Grit Some folks just know how to steer a ship, and that's exactly what Pearl Meyer's Matt Turner and Jannice Koors have been doing. This year, they made it onto the NACD's 2026 Directorship 100 list, swinging as heavy hitters in the Governance Professionals category. It's not just another day at the office when you're honored by the...

Continue Reading
Vipboss Offers Big Black Friday Deals for Adventurers

Updated Category News Views 46

Anticipating Next Year’s Adventures Today Outdoor enthusiasts, listen up! Just because the frost is nipping at your nose doesn’t mean you can’t start dreaming about where the open road or sea will take you next. Vipboss, a known figure in the world of reliable power solutions, is rolling out a Black Friday bonanza, ready to electrify your preparation game with...

Continue Reading
Honeywell Aerospace Faces Class Action Suit Deadline

Updated Category News Views 35

Investors Grapple with Bitter Pill: The HONA Legal Saga Alright, let's dive headfirst into the latest headache for Honeywell Aerospace Inc. (NASDAQ: HONA) shareholders. Earlier this year, HONA found itself in hot water over allegations linked to cybersecurity blunders and misleading statements. If you've invested in this company anytime from June 29 to September 1, 2026,...

Continue Reading
RELEX Solutions: Dominating Supply Chain Assessments

Updated Category News Views 124

Standing Tall in the Supply Chain Arena Every now and then, a company manages to stand out in a way that makes even the seasoned market watchers take notice. This time, it's RELEX Solutions grabbing the spotlight. They've been recognized as a Leader in four separate IDC MarketScape assessments for 2026. It's no small feat considering the crowded stage of supply chain...

Continue Reading
Q32 Bio's Ambitious Steps into Global Conferences

Updated Category News Views 63

Q32 Bio Takes the Stage at Jefferies Who would've thought? Q32 Bio, strutting their stuff at the 2026 Jefferies Global Healthcare Conference in London. Mark your calendars, folks, for November 18, 2026, because that's when they're jumping into the spotlight with a fireside chat. This event isn't just another tiny ripple; it's a chance for Q32 to showcase their innovative...

Continue Reading
LITEON Pushes AI Data Centers with Optical Tech

Updated Category News Views 57

Electronics Meet the Future in Munich When the tech-savvy brains of LITEON hit Munich for electronica 2026, they didn't hold back. This wasn't just your run-of-the-mill showcase; it was a full-on display of technological muscle. Among the dazzling spread were their high-speed optical interconnects. Now, if you're not dialed into what that is, think of it like the train...

Continue Reading
Priority Technology Faces Scrutiny on Proposed Buyout

Updated Category News Views 62

Underlying Questions About Priority Technology's Sale Alright, let's wade into the murky waters of Priority Technology Holdings, Inc. (NASDAQ: PRTH). Now, this isn’t your run-of-the-mill merger. The company’s Chairman and CEO, Thomas Priore, is leading the charge with an investor posse to buy the damn ship. On paper, shareholders are slated to get $8.05 a pop for each...

Continue Reading
Total Wine CEO Pushes Congress for THC Regulation

Updated Category News Views 103

Prohibition or Regulation? The Battle Over THC When it comes down to it, the old dance of prohibition versus regulation is heating up yet again. We're not talking about alcohol this time around but low-dose hemp-derived THC-infused beverages. The folks over at Total Wine & More, with CEO Ryan Ross leading the charge, are shouting from the rooftops for regulation. And,...

Continue Reading
Smirnoff and Broski Unleash Quirky Holiday Merch

Updated Category News Views 102

Surprise in a Box: A Holiday Twist Who knew that a ukulele box would end up sparking more holiday joy than the instrument itself? Smirnoff Ice and social media sensation Brittany Broski are giving us a holiday roll-out that takes a good look at the absurd and runs with it. Instead of strings and melodies, you open that box to find a Smirnoff Ice bottle ready to chill your...

Continue Reading

Top 5 Most Recently Viewed Articles

Emergency Plumbing Solutions to Keep Your Home Safe

Updated Category News Views 125

Reliable Emergency Plumbing Services Available 24/7 Palmetto Plumbing and Drain Cleaning offers top-notch emergency plumbing solutions for both residential and commercial properties. With a dedicated and licensed team, they ensure prompt assistance for urgent plumbing issues, providing customers with the peace of mind they need. Urgent Plumbing Issues & Fast Response...

Continue Reading
Neiro Secures IP Rights and Solidifies Its Position in Crypto

Updated Category News Views 247

Neiro Secures Exclusive IP Rights in Landmark Acquisition Neiro has officially acquired exclusive licensing rights to its intellectual property, marking a pivotal moment in its journey within the cryptocurrency market. This strategic move stems from the collaboration with Atsuko Sato, the caretaker of Kabosu, the beloved Shiba Inu behind the iconic Doge meme, a...

Continue Reading
Revolutionizing Energy: RWE's Lafitte Solar Project Completion

Updated Category News Views 204

RWE Completes Lafitte Solar Project in Louisiana RWE has recently marked a significant milestone with the completion of its Lafitte Solar project, delivering 100 MW of reliable and affordable electricity directly to the Louisiana grid. This initiative not only highlights the company's commitment to renewable energy but also demonstrates its dedication to fostering local...

Continue Reading
Class Action Opportunities for Cardlytics, Inc. Investors

Updated Category News Views 130

Class Action Lawsuit Against Cardlytics, Inc. In a recent announcement, a prominent legal firm has informed investors that they can participate in a class action lawsuit against Cardlytics, Inc. This opportunity arises for individuals who experienced significant losses due to alleged fraudulent conduct associated with the company. Understanding the Class Action The class...

Continue Reading
TaskUs Shareholders: Is $16.50 a Fair Buyout Price?

Updated Category News Views 241

Understanding the TaskUs Buyout Investigation Kaskela Law LLC, a dedicated investor protection firm, has taken a significant step by initiating an investigation into the proposed buyout of TaskUs, Inc. This move aims to ensure the interests of involved shareholders are well represented, particularly focusing on whether the buyout offer of $16.50 per share truly reflects...

Continue Reading